Anti Suicide Drugs Market: By Drug Class (Anti-depressants, Anti-anxiety drugs, Anti-psychotic drugs, NMDA Antagonists, Antibiotic analogues), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospitals, Clinics, Online pharmacies, Retail pharmacies) and Geography    

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Anti Suicide Drugs Market was valued at USD 4 billion in 2022 and expected to reach USD 5.3 billion by 2028 growing at a significant CAGR of 4% from 2023-2029. Suicidal behaviour is defined as the preoccupation or act that is focussed on causing ones own death voluntarily. To have suicidal intent is to have a suicide or deliberate self-killing as one's purpose. Intent refers to the aim, purpose, or goal of the behaviour. The term indicates a conscious desire or wishes to leave or escape from life, and also suggests a resolve to act. This is contrasted with suicidal motivation, or the driving force behind ideation or intent, which need not be conscious. Development of effective anti-suicidal drugs can be a major breakthrough in reducing the death rate.

Currently, non-profit organizations like Stop Suicide, Stop youth suicide and American foundation for suicide prevention are providing social and moral support to the people with suicidal thoughts and tendencies. Increased focus on R&D led to the launch of new range of drugs and a strong pipeline of drugs, which in turn propel the growth of the anti-suicide drugs market. For example, NeuroRX (Acquired by Allergan) completed the phase-II trial for cyclurad (combination of lurasidone and D-Cycloserine, conjugated with ketamine) to treat suicidal tendencies associated with bipolar disorder. Suicide rates are on the rise all across the world, which is one of the market's primary drivers. Suicides accounted for about 1-1.5 percent of all deaths in 2017, according to the World Health Organization. Rising awareness about excellent mental health, shifting, greater focus on research and development leading to the launch of novel anti-suicidal medications are all factors contributing to the market's growth.

Global Anti Suicide Drugs Market Summary

Study Period

2023-29

Base Year

2022

CAGR

4%

Largest Market

North America

Fastest Growing Market

Europe
Anti Suicide Drugs Market Dynamics

Some of the factors which are boosting the growth of Anti Suicide Drugs Market are growing population with depression, increasing different depression disorders such as clinical depressive syndrome, postpartum depression, psychotic depression and seasonal affective disorder etc., and growing suicidal incidences worldwide. As per statistics of WHO around 8,00,000 people are committing suicide every year globally especially among the age group of 15-29 years. However, a dearth of effective therapies, growing drug abuse and rise in usage of unapproved therapies are the few factors which are expected to restrain the growth of anti suicide drugs market.

Key Features of the Reports

  • The anti suicide drugs market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Anti Suicide Drugs Market Segmentation

By Drug Class
  • Anti-depressants
  • Anti-anxiety drugs
  • Anti-psychotic drugs
  • NMDA Antagonists
  • Antibiotic analogues
By Route of Administrat
  • Oral
  • Parenteral
By Distribution Channel
  • Hospitals
  • Clinics
  • Online pharmacies
  • Retail pharmacies
By Geography
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • MEA

Frequently Asked Questions

The Anti suicide drugs market size was valued at USD 4 billion in 2022.

The Anti suicide drugs market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Anti suicide drugs market key players are AstraZeneca plc (UK), Allergan plc (Republic of Ireland), Eli Lilly and Company (UK), H. Lundbeck A/S (Denmark), GlaxoSmithKline plc (UK), Johnson & Johnson (U.S), Merck & Co., Inc. (U.S), Pfizer, Inc. (U.S)

  1. Executive Summary
  2. Global Anti Suicide Drugs Market Introduction
    • Global Anti Suicide Drugs Market Taxonomy
    • Global Anti Suicide Drugs Market Definitions
      • Drug Class
      • Route of Administration
      • Distribution Channel
  1. Global Anti Suicide Drugs Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Anti Suicide Drugs Market Dynamic Factors - Impact Analysis
    • Global Anti Suicide Drugs Market Competition Landscape
    • Epidemiology
  2. Global Anti Suicide Drugs Market Analysis,2018-2022 and Forecast, 2023-2029
    • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Anti Suicide Drugs Market, By Drug Class, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Anti-depressants
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-anxiety drugs
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-psychotic drugs
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • NMDA Antagonists
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antibiotic analogues
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti Suicide Drugs Market Forecast, By Route of Administration, 2018-2022 and Forecast, 2023-2029
    • Oral
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti Suicide Drugs Market Forecast, By Distribution Channel, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail pharmacies
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti Suicide Drugs Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Anti Suicide Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Region, 2018 2024
  2. North America Anti Suicide Drugs MarketAnalysis,2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis 2016 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Anti Suicide Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2023-2029
    • North America Anti Suicide Drugs Market Dynamics Trends
  3. Europe Anti Suicide Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Anti Suicide Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel, and Country,2023-2029
    • Europe Anti Suicide Drugs Market Dynamics Trends
  4. Asia-Pacific Anti Suicide Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Anti Suicide Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel, and Country,2023-2029
    • Asia-Pacific Anti Suicide Drugs Market Dynamics Trends
  5. Latin America Anti Suicide Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Latin America Anti Suicide Drugs Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel, and Country,2023-2029
    • Latin America Anti Suicide Drugs Market Dynamics Trends
  6. Middle East and Africa Anti Suicide Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Anti Suicide Drugs Market - Opportunity Analysis Index, By Drug Class, ByRoute of Administration, By Distribution Channel, and Country,2023-2029
    • MEA Anti Suicide Drugs Market Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • AstraZeneca plc (UK)
      • Allergan plc, Eli Lilly and Company (UK)
      • Lundbeck A/S (Denmark)
      • GlaxoSmithKline plc (UK)
      • Johnson & Johnson (U.S)
      • Merck & Co., Inc. (U.S)
      • Pfizer, Inc. (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • AstraZeneca plc (UK)
  • Allergan plc (Republic of Ireland)
  • Eli Lilly and Company (UK)
  • H. Lundbeck A/S (Denmark)
  • GlaxoSmithKline plc (UK)
  • Johnson & Johnson (U.S)
  • Merck & Co., Inc. (U.S)
  • Pfizer, Inc. (U.S)